SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cipla

Cipla

BSE: 500087|NSE: CIPLA|ISIN: INE059A01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 17, 16:00
592.60
9.2 (1.58%)
VOLUME 175,139
LIVE
NSE
Feb 17, 15:48
593.25
8.65 (1.48%)
VOLUME 1,209,276
News on Cipla
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Cipla, Serum Institute launch Hepatitis B vaccine

12.54 pm | 18 Feb 2017 |  Source: PTI

As per Cipla's co-exclusive agreement with SII, the former will market the vaccine for adults while the latter will market it for adults and children,...

Stocks in news: SBI, TCS, Tata Steel, Cipla, SBT, SBBJ, Cyient 

8.00 am | 16 Feb 2017 |  Source: CNBC-TV18

SBI | TCS | Sun Pharma | Tata Steel | Cipla | Hindalco Industries | Petronet LNG | State Bank of Bikaner and Jaipur | State Bank of Mysore | State Ban...

Buy Cipla; target of Rs 740: Centrum

3.30 pm | 15 Feb 2017 |  Source: Moneycontrol.com

Centrum is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 740 in its research report dated February 08, 2017....

Cipla joins the race to build specialty branded business in US

4.56 pm | 13 Feb 2017 |  Source: Moneycontrol.com

Cipla will be falling back on its core strengths in respiratory and central nervous system (CNS) for build-up of specialty pipeline in US. The company...

Hold Cipla; target of Rs 575: ICICI Direct

2.13 pm | 13 Feb 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Cipla with a target price of Rs 575 in its research report dated February 09, 2017....

Buy Cipla; target of Rs 690: KR Choksey

10.46 am | 13 Feb 2017 |  Source: Moneycontrol.com

KR Choksey is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 690 in its research report dated February 09, 2017....

Hold Cipla; target of Rs 500: Edelweiss

2.49 pm | 11 Feb 2017 |  Source: Moneycontrol.com

Edelweiss recommended hold rating on Cipla with a target price of Rs 500 in its research report dated February 08, 2017. ...

Buy Adani Ports, Arvind; sell Cipla: Sandeep Wagle 

3.13 pm | 10 Feb 2017 |  Source: CNBC-TV18

Sandeep Wagle of powermywealth.com suggests buying Adani Ports and Arvind and advises selling Cipla....

Hold Cipla, may test Rs 700: Vijay Chopra 

2.58 pm | 09 Feb 2017 |  Source: CNBC-TV18

Vijay Chopra of enochventures.com is of the view that one may hold Cipla....

Buy Cipla, Lupin, M&M Financial Services: Sudarshan Sukhani 

10.50 am | 09 Feb 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Cipla, Lupin and M&M Financial Services....

Buy, sell, hold: 10 crucial stocks to watch out post Q3 results

10.02 am | 09 Feb 2017 |  Source: CNBC-TV18

While retaining overweight rating with increased target price at Rs 185 (from Rs 180 earlier), JPMorgan expects NTPC to close the acquisition of phase...

Stocks in news: Hero Moto, Lupin, Cipla, Idea, Axis, Thermax 

8.00 am | 09 Feb 2017 |  Source: CNBC-TV18

Hero Motocorp | Lupin | Cipla | Bank of India | eClerx Services | Ratnamani Metals | Healthcare Global | Reliance Power | Union Bank | Thermax | Indra...

Cipla: Outcome of board meeting

9.38 pm | 08 Feb 2017 |  Source: Moneycontrol.com

Cipla has now informed that the Board of Directors at their meeting held on February 08, 2017 has further deliberated on the proposal relating to fund...

Dr Reddy's US launch of cancer drug delayed over compliance woes

6.00 pm | 08 Feb 2017 |  Source: Moneycontrol.com

The drug maker’s much anticipated launch of key blood cancer treatment drug imatinib mesylate in US – is facing the risk of further delay, as a pa...

Cipla Q3 profit up 44% at Rs 375 cr on strong operational income 

4.49 pm | 08 Feb 2017 |  Source: Moneycontrol.com

Healthcare company Cipla reported a stead set of earnings in the quarter ended December 2017. Profit grew by 43.9 percent year-on-year to Rs 375 crore...

Stocks in news: Infosys, Axis, Tata Steel, Bharti, Quess, Titan 

8.00 am | 08 Feb 2017 |  Source: CNBC-TV18

Infosys | Idea Cellular | Axis Bank | Tata Steel | Bharti Airtel | Bharat Forge | Hero Motocorp | Godawari Power | Jubilant Life Sciences | NHPC | Que...

Cipla Q3 profit seen up 5%; US, India & EMs may lift revenue 20% 

4.52 pm | 07 Feb 2017 |  Source: CNBC-TV18

Analysts expect India business growth in range of 11-20 percent YoY while Africa and Rest of the World may report steady sales. API may see slower sal...

Buy, sell, hold: 7 stocks analysts are watching out

10.11 am | 07 Feb 2017 |  Source: Moneycontrol.com

Morgan Stanley also says Jubilant Foodworks' earnings are ahead of estimates and there was impressive cost control. It is best placed to capitalise on...

Buy Hindustan Unilever, Cipla: Rahul Mohindar 

3.03 pm | 06 Feb 2017 |  Source: CNBC-TV18

According to Rahul Mohindar of viratechindia.com, one can buy Hindustan Unilever and Cipla....

Good Q3 but Dr Reddy's still far from sustainable growth: Expert 

11.25 am | 06 Feb 2017 |  Source: CNBC-TV18

Surajit Pal, Research Analyst at Prabhudas Lilladher, said the pharma sector is undergoing a transition and all the large midcaps will underperform....

1 2 3 4 5 6
Quick Links for Cipla
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.